Search Results

Viewing Page 5 of 22 | Showing Results 41 - 50 of 211

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia (BRIGHT AML1019)

Glasdegib is being studied in combination with azacitidine for the treatment of adult patients with previously untreated acute myeloid leukemia...

Raya Mawad, MD

Swedish Cancer Institute

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion (BEAM)

The work proposed herein aims to provide the first prospective, randomized comparative efficacy data between Melphalan and BEAM treatment regimen...

William Bensinger, MD

Swedish Cancer Institute

Robotic-assisted and Laparoscopic Right Colectomy Study - Intracorporeal vs. Extracorporeal Anastomoses (ANCOR)

This is a prospective multicenter observational study to evaluate outcomes of intracorporeal and extracorporeal anastomoses for robotic-assisted...

Amir Bastawrous, MD

Swedish Cancer Institute

Compare Fallopian Tube Cells Collected by MAKO 7 With Removed Ovarian/Tubal Tissue to Determine Presence of Malignant or Benign Cells (nCYT)

Prospective, multi-center, non-randomized study to assess the ability of the MAKO 7 device to collect cell samples from the fallopian tube that...

Charles Drescher, MD

Swedish Cancer Institute

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

This is a Phase 1 platform protocol designed to evaluate various targeted agents for the treatment of relapsed/refractory aggressive Non-Hodgkin's...

John Pagel, MD

Swedish Cancer Institute

Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System (NEWTON)

Malignant pleural effusion remains a debilitating complication of end stage cancer, which can be greatly improved by the introduction of the...

Christopher Gilbert

Swedish Cancer Institute

A Trial of TTI-622 in Patients With Advanced Relapsed or Refractory Lymphoma or Myeloma (TTI-622-01)

Multicenter, open-label, phase 1a/1b Dose Escalation and Expansion Trial of TTI-622 in Patients with Advanced Relapsed or Refractory Lymphoma or...

Krish Patel, MD

Swedish Cancer Institute

A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of KTE-X19 in Adult Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia (ZUMA-8)

The primary objective of this study is to evaluate the safety (Phase 1) and efficacy (Phase 2) of KTE-X19 in adults with relapsed/refractory...

John Pagel, M.D.

Swedish Cancer Institute

A Dose Escalation Study of RO7082859 as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

This is a Phase I, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK)...

Krish Patel, MD

Swedish Cancer Institute

A Phase 1 Dose-Escalation and Cohort-Expansion Study of VLS -101 in Subjects With Hematological Malignancies

A Phase 1 Dose-Escalation Study of VLS-101 in Hematological Malignancies

Krish Patel, M.D.

Swedish Cancer Institute

Viewing Page 5 of 22 | Showing Results 41 - 50 of 211